TY  - GEN
AU  - Secord,Angeles Alvarez
AU  - Teoh,Deanna K
AU  - Barry,William T
AU  - Yu,Miao
AU  - Broadwater,Gloria
AU  - Havrilesky,Laura J
AU  - Lee,Paula S
AU  - Berchuck,Andrew
AU  - Lancaster,Johnathan
AU  - Wenham,Robert M
TI  - A phase I trial of dasatinib, an SRC-family kinase inhibitor, in combination with paclitaxel and carboplatin in patients with advanced or recurrent ovarian cancer
SN  - 1557-3265
PY  - 2013///0503
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - administration & dosage
KW  - Carboplatin
KW  - Dasatinib
KW  - Dose-Response Relationship, Drug
KW  - Drug Administration Schedule
KW  - Female
KW  - Humans
KW  - Maximum Tolerated Dose
KW  - Middle Aged
KW  - Neoplasm Recurrence, Local
KW  - drug therapy
KW  - Neoplasm Staging
KW  - Ovarian Neoplasms
KW  - Paclitaxel
KW  - Protein Kinase Inhibitors
KW  - Pyrimidines
KW  - Thiazoles
KW  - src-Family Kinases
KW  - antagonists & inhibitors
N1  - Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1158/1078-0432.CCR-12-0507
ER  -